| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
|---|
| What is an ATC-Code? | ATC-Overview |
|
| | | IP | CI | | ferro sanol | 50 Capsule(s) | 6.86 | 12.65 | 10 % | | gélules à libération modifiée: Ferrum 100 mg | UCB-Pharma SA | D / SL | FB | | G |  |
|
| | | IP | CI | | Ferrum Hausmann - T | 30 Capsule(s) | 4.52 | 8.35 | 10 % | | Delayed release capsules: Ferrum(ii) 100 mg | Vifor (International) Inc. | D / SL | FB | | G |  |
| | | IP | CI | | Ferrum Hausmann - T | 100 Capsule(s) | 12.76 | 23.55 | 10 % | | Delayed release capsules: Ferrum(ii) 100 mg | Vifor (International) Inc. | D / SL | FB | | G |  |
|
| | | IP | CI | | Tardyferon | 30 | 4.58 | 8.45 | 10 % | | Delayed release tablets: Ferrum(ii) 80 mg | Pierre Fabre Pharma SA | D / SL | FB | | G |  |
| | | IP | CI | | Tardyferon | 100 | 13.82 | 25.50 | 10 % | | Delayed release tablets: Ferrum(ii) 80 mg | Pierre Fabre Pharma SA | D / SL | FB | | G |  |
| | | IP | CI | | Ferro-Gradumet | 30 Tablet(s) | | 10.90 | k.A. | | Delayed release tablets: Ferrum(ii) 105 mg | FARMACEUTICA TEOFARMA SUISSE SA | D | FB | | G |  |
| | | IP | CI | | Ferro-Gradumet | 90 Tablet(s) | | 28.00 | k.A. | | Delayed release tablets: Ferrum(ii) 105 mg | FARMACEUTICA TEOFARMA SUISSE SA | D | FB | | G |  |
|
| | | IP | CI | | Maltofer | 30 Tablet(s) | 6.86 | 12.65 | 10 % | | Chewing tablets: Ferrum(iii) 100 mg | Vifor (International) Inc. | D / SL | FB | | G |  |
| | | IP | CI | | Maltofer | 100 Tablet(s) | 19.46 | 35.95 | 10 % | | Chewing tablets: Ferrum(iii) 100 mg | Vifor (International) Inc. | D / SL | FB | | G |  |
| | | IP | CI | | Maltofer | 150 ml | 6.00 | 11.10 | 10 % | | Sirup: Ferrum(iii) 10 mg/ml | Vifor (International) Inc. | D / SL | FB | | G |  |
| | | IP | CI | | Maltofer - T | 30 Tablet(s) | 6.86 | 12.65 | 10 % | | Coated tablets: Ferrum(iii) 100 mg | Vifor (International) Inc. | D / SL | FB | | G |  |
| | | IP | CI | | Maltofer - T | 100 Tablet(s) | 19.46 | 35.95 | 10 % | | Coated tablets: Ferrum(iii) 100 mg | Vifor (International) Inc. | D / SL | FB | | G |  |
| | | IP | CI | | Maltofer | 30 ml | 4.98 | 9.20 | 10 % | | Tropfen zum Einnehmen: Ferrum(iii) 50 mg/ml | Vifor (International) Inc. | D / SL | FB | | G |  |
| | | IP | CI | | Maltofer | 10 x 5 ml | | | k.A. | | Lösung zum Einnehmen im Einzeldosenbehältnis: Ferrum(iii) 100mg / 5ml | Vifor (International) Inc. | D | FB | | G |  |
|
| | SIP | IP | | | Ferinject 100 mg / 2 ml | 5 1 ampoule(s) à 2 ml | 106.49 | 127.65 | 20 % | | Dispersion zur Injektion/Infusion: Ferrum 100mg / 2ml | Vifor (International) Inc. | B / SL / SO | FB | | G |  |
| | SIP | IP | | | Ferinject 500 mg / 10 ml | ampoule(s) à 10 ml | 106.49 | 127.65 | 20 % | | Dispersion zur Injektion/Infusion: Ferrum 500mg / 10ml | Vifor (International) Inc. | B / SL / SO | FB | | G |  |
| | SIP | IP | | | Ferinject 1000 mg / 20 ml | ampoule(s) à 20 ml | 212.99 | 238.90 | 20 % | | Dispersion zur Injektion/Infusion: Ferrum 1000mg / 20ml | Vifor (International) Inc. | B / SL / SO | FB | | G |  |
| | SIP | IP | | | Ferinject 500 mg / 10 ml | 5 1 ampoule(s) à 10 ml | 532.47 | 572.55 | 20 % | | Dispersion zur Injektion/Infusion: Ferrum 500mg / 10ml | Vifor (International) Inc. | B / SL / SO | FB | | G |  |
| | | IP | | CM | Feryxa 100 mg / 2 ml | 5 x 2 ml | 35.14 | 54.45 | 10 % | | Dispersion zur Injektion/Infusion: Ferrum 100mg / 2ml | Vifor (International) Inc. | B / SL / SO | FB | | G |  |
| | | IP | | CM | Feryxa 500 mg / 10 ml | 10 ml | 35.14 | 54.45 | 10 % | | Dispersion zur Injektion/Infusion: Ferrum 500mg / 10ml | Vifor (International) Inc. | B / SL / SO | FB | | G |  |
| | | IP | | CM | Feryxa 1000 mg / 20 ml | 20 ml | 70.28 | 92.45 | 10 % | | Dispersion zur Injektion/Infusion: Ferrum 1000mg / 20ml | Vifor (International) Inc. | B / SL / SO | FB | | G |  |
| | | IP | | CM | Feryxa 500 mg / 10 ml | 5 x 10 ml | 175.71 | 206.55 | 10 % | | Dispersion zur Injektion/Infusion: Ferrum 500mg / 10ml | Vifor (International) Inc. | B / SL / SO | FB | | G |  |
| | | IP | | | Eisencarboxymaltose Sandoz 100 mg / 2 ml | 5 x 2 ml | 31.95 | 51.15 | 10 % | | Infusion solution: Ferrum 100mg / 2ml | Sandoz Pharmaceuticals AG | ● B / SL / SG | FB | | G |  |
| | | IP | | | Eisencarboxymaltose Sandoz 500 mg / 10 ml | 10 ml | 31.95 | 51.15 | 10 % | | Infusion solution: Ferrum 500mg / 10ml | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | | IP | | | Eisencarboxymaltose Sandoz 1000 mg/ 20 ml | 20 ml | 63.90 | 85.90 | 10 % | | Infusion solution: Ferrum 1000mg / 20ml | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | | IP | | | Eisencarboxymaltose Sandoz 500 mg / 10 ml | 5 x 10 ml | 159.74 | 190.15 | 10 % | | Infusion solution: Ferrum 500mg / 10ml | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | | IP | | | Ferrum-Mepha Inject 100 mg / 2 ml | 5 x 2 ml | 31.95 | 51.15 | 10 % | | Dispersion zur Injektion/Infusion: Ferrum 100mg / 2ml | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | | IP | | | Ferrum-Mepha Inject 500 mg / 10 ml | 10 ml | 31.95 | 51.15 | 10 % | | Dispersion zur Injektion/Infusion: Ferrum 500mg / 10ml | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | | IP | | | Ferrum-Mepha Inject 1000 ml / 20 ml | 20 ml | 63.90 | 85.90 | 10 % | | Dispersion zur Injektion/Infusion: Ferrum 1000mg / 20ml | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | | IP | | | Ferrum-Mepha Inject 500 mg / 10 ml | 5 x 10 ml | 159.74 | 190.15 | 10 % | | Dispersion zur Injektion/Infusion: Ferrum 500mg / 10ml | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | | IP | | | FerMed 20 mg/ml | 5 x 5 ml | 61.83 | 83.65 | 10 % | | Infusion solution: Ferrum 100 mg | Salmon Pharma GmbH | B / SL | FB | | G |  |
| | | IP | | | Venofer 100mg / 5 ml | 5 1 ampoule(s) à 5 ml | 80.54 | 104.00 | 10 % | | Injection solution: Ferrum(iii) 100 mg | Vifor (International) Inc. | B / SL | FB | | G |  |
| | | IP | | | Monofer 100 mg / 1 ml | 5 x 1 ml | 131.65 | 159.60 | 10 % | | Solution for intravenous injection/infusion: Ferrum(iii) 100 mg | Pierre Fabre Pharma SA | B / SL | FB | | G |  |
| | | IP | | | Monofer 500 mg / 5 ml | 5 ml | 131.65 | 159.60 | 10 % | | Solution for intravenous injection/infusion: Ferrum(iii) 500 mg | Pierre Fabre Pharma SA | B / SL | FB | | G |  |
| | | IP | | | Monofer 500 mg / 5 ml | 5 x 5 ml | 658.26 | 732.30 | 10 % | | Solution for intravenous injection/infusion: Ferrum(iii) 500 mg | Pierre Fabre Pharma SA | B / SL | FB | | G |  |
| | | IP | | | Monofer 1000 mg / 10 ml | 10 ml | 263.30 | 302.75 | 10 % | | Solution for intravenous injection/infusion: Ferrum(iii) 1000 mg | Pierre Fabre Pharma SA | B / SL | FB | | G |  |
| | | IP | | | Monofer 1000 mg / 10 ml | 2 x 10 ml | 526.61 | 589.15 | 10 % | | Solution for intravenous injection/infusion: Ferrum(iii) 1000 mg | Pierre Fabre Pharma SA | B / SL | FB | | G |  |
| | | IP | | | Venofer 100mg / 5 ml | 5 x 5 ml | | | k.A. | | Injection solution: Ferrum(iii) 100 mg | Vifor (International) Inc. | B | FB | | G |  |
| | | IP | | CM | Viyana 100 mg / 2 ml | 5 x 2 ml | | | k.A. | | Dispersion zur Injektion/Infusion: Ferrum 100mg / 2ml | Vifor (International) Inc. | B | FB | | G |  |
| | | IP | | CM | Viyana 500 mg / 10 ml | 10 ml | | | k.A. | | Dispersion zur Injektion/Infusion: Ferrum 500mg / 10ml | Vifor (International) Inc. | B | FB | | G |  |
| | | IP | | CM | Viyana 1000 mg / 20 ml | 20 ml | | | k.A. | | Dispersion zur Injektion/Infusion: Ferrum 1000mg / 20ml | Vifor (International) Inc. | B | FB | | G |  |
| | | IP | | CM | Viyana 500 mg / 10 ml | 5 x 10 ml | | | k.A. | | Dispersion zur Injektion/Infusion: Ferrum 500mg / 10ml | Vifor (International) Inc. | B | FB | | G |  |
| | | IP | | | Eisencarboxymaltose Sandoz 100 mg / 2 ml | 2 ml | | | k.A. | | Infusion solution: Ferrum 100mg / 2ml | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | SIP | IP | | | Ferinject 100 mg / 2 ml | ampoule(s) à 2 ml | | | k.A. | | Dispersion zur Injektion/Infusion: Ferrum 100mg / 2ml | Vifor (International) Inc. | B | FB | | G |  |
| | | IP | | | Rienso | 2 Durchstechflasche(n) | 280.50 | 338.40 | k.A. | | Lösung zur intravenösen Injektion: Ferrum 510mg / 17ml | Takeda Pharma AG | B | FB | | G |  |
| | | IP | | | Rienso | 6 Durchstechflasche(n) | | | k.A. | | Lösung zur intravenösen Injektion: Ferrum 510mg / 17ml | Takeda Pharma AG | B | FB | | G |  |
| | | IP | | | Rienso | 2 x 10 Durchstechflasche(n) | | | k.A. | | Lösung zur intravenösen Injektion: Ferrum 510mg / 17ml | Takeda Pharma AG | B | FB | | G |  |
| | | IP | | | Rienso | 6 x 10 Durchstechflasche(n) | | | k.A. | | Lösung zur intravenösen Injektion: Ferrum 510mg / 17ml | Takeda Pharma AG | B | FB | | G |  |
| | | IP | | | Rienso | Durchstechflasche(n) | 140.25 | 177.40 | k.A. | | Lösung zur intravenösen Injektion: Ferrum 510mg / 17ml | Takeda Pharma AG | B | FB | | G |  |
| | | IP | | | Rienso | 10 Durchstechflasche(n) | | | k.A. | | Lösung zur intravenösen Injektion: Ferrum 510mg / 17ml | Takeda Pharma AG | B | FB | | G |  |
|
| | | IP | CI | | Gyno-Tardyferon | 30 | 4.12 | 7.60 | 10 % | | Delayed release tablets: 2 Active Agents | Pierre Fabre Pharma SA | D / SL | FB | | G |  |
| | | IP | CI | | Gyno-Tardyferon | 100 | 12.49 | 23.05 | 10 % | | Delayed release tablets: 2 Active Agents | Pierre Fabre Pharma SA | D / SL | FB | | G |  |
|
| | | IP | CI | | Maltofer Fol - T | 30 Tablet(s) | 5.35 | 9.90 | 10 % | | Chewing tablets: 2 Active Agents | Vifor (International) Inc. | D / SL | FB | | G |  |
| | | IP | CI | | Maltofer Fol - T | 100 Tablet(s) | 15.68 | 28.95 | 10 % | | Chewing tablets: 2 Active Agents | Vifor (International) Inc. | D / SL | FB | | G |  |
|
| | | IP | CI | | Elevit Pronatal - T | 30 | | | k.A. | | Coated tablets: 19 Active Agents | Bayer (Schweiz) AG | D | FB | | G |  |
| | | IP | CI | | Elevit Pronatal - T | 100 | | | k.A. | | Coated tablets: 19 Active Agents | Bayer (Schweiz) AG | D | FB | | G |  |
| | | IP | CI | | Natabec | 30 Capsule(s) | | | k.A. | | Capsules: 11 Active Agents | Pfizer AG | C | FB | | G |  |
| | | IP | CI | | Natabec | 100 Capsule(s) | | | k.A. | | Capsules: 11 Active Agents | Pfizer AG | C | FB | | G |  |
|
| | | IP | | | Vitamin B12 Amino | 10 x 1 ml | 8.35 | 25.50 | 10 % | | Injection solution: Cyanocobalaminum 1 mg/ml | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B / SL | FB | | G |  |
| | | IP | | | Vitarubin | 10 x 1 ml | 8.35 | 25.50 | 10 % | | Injection solution: Cyanocobalaminum 1 mg/ml | Streuli Pharma AG | B / SL | FB | | G |  |
| L | | IP | CI | | Vitamin B12 1000 μg Dermapharm | 30 | 8.72 | 16.10 | 10 % | | Coated tablets: Cyanocobalaminum 1000 µg | Dermapharm AG | D / SL | FB | | G |  |
| L | | IP | CI | | Vitamin B12 1000 μg Dermapharm | 60 | 11.20 | 20.70 | 10 % | | Coated tablets: Cyanocobalaminum 1000 µg | Dermapharm AG | D / SL | FB | | G |  |
| L | | IP | CI | | Vitarubin Oral | 30 | 9.69 | 17.90 | 10 % | | Coated tablets: Cyanocobalaminum 1 mg | Streuli Pharma AG | D / SL | FB | | G |  |
| L | | IP | CI | | Vitarubin Oral | 100 | 20.07 | 37.05 | 10 % | | Coated tablets: Cyanocobalaminum 1 mg | Streuli Pharma AG | D / SL | FB | | G |  |
| | | IP | | | Vitamin B12 Amino | 100 x 1 ml | | | k.A. | | Injection solution: Cyanocobalaminum 1 mg/ml | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | | IP | | | Vitarubin | 5 x 1 ml | 4.65 | 14.30 | k.A. | | Injection solution: Cyanocobalaminum 1 mg/ml | Streuli Pharma AG | B | FB | | G |  |
| | | IP | CI | | Vitamin B12 1000 μg Dermapharm | 50 | | | k.A. | | Coated tablets: Cyanocobalaminum 1000 µg | Dermapharm AG | D | FB | | G |  |
| | | IP | CI | | Vitamin B12 1000 μg Dermapharm | 100 | | | k.A. | | Coated tablets: Cyanocobalaminum 1000 µg | Dermapharm AG | D | FB | | G |  |
| | | | | | B12 Ankermann 1000 μg | 10 | | | k.A. | | überzogene Tabletten: Cyanocobalaminum 1 mg | Maras AG | D | FB | | G |  |
| | | | | | B12 Ankermann 1000 μg | 50 | | | k.A. | | überzogene Tabletten: Cyanocobalaminum 1 mg | Maras AG | D | FB | | G |  |
| | | | | | B12 Ankermann 1000 μg | 100 | | | k.A. | | überzogene Tabletten: Cyanocobalaminum 1 mg | Maras AG | D | FB | | G |  |
|
| | | IP | CI | | Vitasprint B12 | 10 ampoule(s) | | | k.A. | | Solution (oral): 2 Active Agents | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | | IP | CI | | Vitasprint B12 | 30 ampoule(s) | | | k.A. | | Solution (oral): 2 Active Agents | Haleon Schweiz AG | D / LPPV | FB | | G |  |
|
| L | | IP | CI | | Binocrit 1000 IE/0,5 ml | 6 x 0.5 ml | 37.40 | 57.10 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 1000U.I. / 0.5ml | Sandoz Pharmaceuticals AG | A / SL | FB | | G |  |
| L | | IP | CI | | Binocrit 2000 IE/1 ml | 6 x 1 ml | 74.69 | 97.65 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 2000 UI/ml | Sandoz Pharmaceuticals AG | A / SL | FB | | G |  |
| L | | IP | CI | | Binocrit 3000 IE/0,3 ml | 6 x 0.3 ml | 111.97 | 138.20 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 3000U.I. / 0.3ml | Sandoz Pharmaceuticals AG | A / SL | FB | | G |  |
| L | | IP | CI | | Binocrit 4000 IE/0,4 ml | 6 x 0.4 ml | 149.15 | 178.65 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 4000U.I. / 0.4ml | Sandoz Pharmaceuticals AG | A / SL | FB | | G |  |
| L | | IP | CI | | Binocrit 5000 IE/0,5 ml | 6 x 0.5 ml | 186.61 | 219.35 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 5000U.I. / 0.5ml | Sandoz Pharmaceuticals AG | A / SL | FB | | G |  |
| L | | IP | CI | | Binocrit 6000 IE/0,6 ml | 6 x 0.6 ml | 223.73 | 259.75 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 6000U.I. / 0.6ml | Sandoz Pharmaceuticals AG | A / SL | FB | | G |  |
| L | | IP | CI | | Binocrit 8000 IE/0,8 ml | 6 x 0.8 ml | 297.96 | 340.45 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 8000U.I. / 0.8ml | Sandoz Pharmaceuticals AG | A / SL | FB | | G |  |
| L | | IP | CI | | Binocrit 10000 IE/1 ml | 6 x 1 ml | 372.82 | 421.90 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 10000 UI/ml | Sandoz Pharmaceuticals AG | A / SL | FB | | G |  |
| L | | IP | CI | | Eprex 1000 U | 6 1 syringe(s) à 0.5 ml | 41.43 | 61.25 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 1000U.I. / 0.5ml | Janssen-Cilag AG | A / SL | FB | | G |  |
| L | | IP | CI | | Eprex 2000 U | 6 1 syringe(s) à 0.5 ml | 82.85 | 106.00 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 2000U.I. / 0.5ml | Janssen-Cilag AG | A / SL | FB | | G |  |
| L | | IP | CI | | Eprex 3000 U | 6 1 syringe(s) à 0.3 ml | 124.28 | 150.80 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 3000U.I. / 0.3ml | Janssen-Cilag AG | A / SL | FB | | G |  |
| L | | IP | CI | | Eprex 4000 U | 6 1 syringe(s) à 0.4 ml | 165.72 | 195.65 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 4000U.I. / 0.4ml | Janssen-Cilag AG | A / SL | FB | | G |  |
| L | | IP | CI | | Eprex 5000 U | 6 1 syringe(s) à 0.5 ml | 207.14 | 240.45 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 5000U.I. / 0.5ml | Janssen-Cilag AG | A / SL | FB | | G |  |
| L | | IP | CI | | Eprex 10000 U | 6 1 syringe(s) à 1 ml | 414.28 | 464.40 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 10000 UI/ml | Janssen-Cilag AG | A / SL | FB | | G |  |
| L | | IP | CI | | Eprex 20000 U | syringe(s) à 0.5 ml | 138.09 | 166.60 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 20000U.I. / 0.5ml | Janssen-Cilag AG | A / SL | FB | | G |  |
| L | | IP | CI | | Eprex 30000 U | syringe(s) à 0.75 ml | 207.14 | 241.70 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 30000U.I. / 0.75ml | Janssen-Cilag AG | A / SL | FB | | G |  |
| L | | IP | CI | | Eprex 40000 U | syringe(s) à 1 ml | 276.19 | 316.80 | 10 % | | Injection solution in prefilled syringe: Epoetinum Alfa 40000 UI/ml | Janssen-Cilag AG | A / SL | FB | | G |  |
| L | | IP | CI | | Recormon PS 2000 U.I./0,3 mL | 6 | 84.49 | 108.30 | 10 % | | Injection solution in prefilled syringe: Epoetinum Beta 2000U.I. / 0.3ml | Roche Pharma (Schweiz) AG | ● A / SL | FB | | G |  |
| L | | IP | CI | | Recormon PS 3000 U.I./0,3 mL | 6 | 126.75 | 154.25 | 10 % | | Injection solution in prefilled syringe: Epoetinum Beta 3000U.I. / 0.3ml | Roche Pharma (Schweiz) AG | ● A / SL | FB | | G |  |
| L | | IP | CI | | Recormon PS 4000 U.I./0,3 mL | 6 | 168.99 | 200.20 | 10 % | | Injection solution in prefilled syringe: Epoetinum Beta 4000U.I. / 0.3ml | Roche Pharma (Schweiz) AG | ● A / SL | FB | | G |  |
| L | | IP | CI | | Recormon PS 5000 U.I./0,3 mL | 6 | 211.24 | 246.15 | 10 % | | Injection solution in prefilled syringe: Epoetinum Beta 5000U.I. / 0.3ml | Roche Pharma (Schweiz) AG | ● A / SL | FB | | G |  |
| L | | IP | CI | | Recormon PS 10'000 U.I./0,6 mL | 6 | 405.99 | 457.95 | 10 % | | Injection solution in prefilled syringe: Epoetinum Beta 10000U.I. / 0.6ml | Roche Pharma (Schweiz) AG | A / SL | FB | | G |  |
| L | | IP | CI | | Recormon PS 30'000 U.I./0,6 mL | 4 | 811.98 | 899.50 | 10 % | | Injection solution in prefilled syringe: Epoetinum Beta 30000U.I. / 0.6ml | Roche Pharma (Schweiz) AG | A / SL | FB | | G |  |
| L | | IP | CI | | EpoTheta-Teva 1000 | 6 syringe(s) | 40.47 | 60.45 | 10 % | | Fertigspritze mit Injektionslösung: Epoetinum Theta 1000U.I. / 0.5ml | Teva Pharma AG | A / SL | FB | | G |  |
| L | | IP | CI | | EpoTheta-Teva 2000 | 6 syringe(s) | 80.96 | 104.45 | 10 % | | Fertigspritze mit Injektionslösung: Epoetinum Theta 2000U.I. / 0.5ml | Teva Pharma AG | A / SL | FB | | G |  |
| L | | IP | CI | | EpoTheta-Teva 3000 | 6 syringe(s) | 121.44 | 148.50 | 10 % | | Fertigspritze mit Injektionslösung: Epoetinum Theta 3000U.I. / 0.5ml | Teva Pharma AG | A / SL | FB | | G |  |
| L | | IP | CI | | EpoTheta-Teva 4000 | 6 syringe(s) | 161.93 | 192.50 | 10 % | | Fertigspritze mit Injektionslösung: Epoetinum Theta 4000U.I. / 0.5ml | Teva Pharma AG | A / SL | FB | | G |  |
| L | | IP | CI | | EpoTheta-Teva 5000 | 6 syringe(s) | 201.79 | 235.85 | 10 % | | Fertigspritze mit Injektionslösung: Epoetinum Theta 5000U.I. / 0.5ml | Teva Pharma AG | A / SL | FB | | G |  |
| L | | IP | CI | | EpoTheta-Teva 10'000 | 6 syringe(s) | 384.87 | 435.00 | 10 % | | Fertigspritze mit Injektionslösung: Epoetinum Theta 10000 UI/ml | Teva Pharma AG | A / SL | FB | | G |  |
| L | | IP | CI | | EpoTheta-Teva 20'000 | 4 syringe(s) | 531.08 | 594.00 | 10 % | | Fertigspritze mit Injektionslösung: Epoetinum Theta 20000 UI/ml | Teva Pharma AG | A / SL | FB | | G |  |
| L | | IP | CI | | EpoTheta-Teva 30'000 | 4 syringe(s) | 780.15 | 864.90 | 10 % | | Fertigspritze mit Injektionslösung: Epoetinum Theta 30000 UI/ml | Teva Pharma AG | A / SL | FB | | G |  |
| | | IP | CI | | Binocrit 7000 IE/0,7 ml | 6 x 0.7 ml | 586.75 | 707.35 | k.A. | | Injection solution in prefilled syringe: Epoetinum Alfa 7000U.I. / 0.7ml | Sandoz Pharmaceuticals AG | A | FB | | G |  |
| | | IP | CI | | Binocrit 9000 IE/0,9 ml | 6 x 0.9 ml | 754.50 | 904.90 | k.A. | | Injection solution in prefilled syringe: Epoetinum Alfa 9000U.I. / 0.9ml | Sandoz Pharmaceuticals AG | A | FB | | G |  |
| | | IP | CI | | Eprex 6000 U | 6 1 syringe(s) à 0.6 ml | 364.87 | 435.25 | k.A. | | Injection solution in prefilled syringe: Epoetinum Alfa 6000U.I. / 0.6ml | Janssen-Cilag AG | A | FB | | G |  |
| | | IP | CI | | Eprex 8000 U | 6 1 syringe(s) à 0.8 ml | 486.49 | 574.90 | k.A. | | Injection solution in prefilled syringe: Epoetinum Alfa 8000U.I. / 0.8ml | Janssen-Cilag AG | A | FB | | G |  |
| | | IP | CI | | Eprex 30000 U | 4 1 syringe(s) à 0.75 ml | 1833.36 | 2070.20 | k.A. | | Injection solution in prefilled syringe: Epoetinum Alfa 30000U.I. / 0.75ml | Janssen-Cilag AG | A | FB | | G |  |
| | | IP | CI | | Eprex 40000 U | 4 1 syringe(s) à 1 ml | 2444.42 | 2739.75 | k.A. | | Injection solution in prefilled syringe: Epoetinum Alfa 40000 UI/ml | Janssen-Cilag AG | A | FB | | G |  |
| | | IP | CI | | EpoTheta-Teva 10'000 | syringe(s) | | | k.A. | | Fertigspritze mit Injektionslösung: Epoetinum Theta 10000 UI/ml | Teva Pharma AG | A | FB | | G |  |
| | | IP | CI | | EpoTheta-Teva 10'000 | 4 syringe(s) | | | k.A. | | Fertigspritze mit Injektionslösung: Epoetinum Theta 10000 UI/ml | Teva Pharma AG | A | FB | | G |  |
| | | IP | CI | | EpoTheta-Teva 20'000 | syringe(s) | | | k.A. | | Fertigspritze mit Injektionslösung: Epoetinum Theta 20000 UI/ml | Teva Pharma AG | A | FB | | G |  |
| | | IP | CI | | EpoTheta-Teva 20'000 | 6 syringe(s) | | | k.A. | | Fertigspritze mit Injektionslösung: Epoetinum Theta 20000 UI/ml | Teva Pharma AG | A | FB | | G |  |
| | | IP | CI | | EpoTheta-Teva 30'000 | syringe(s) | | | k.A. | | Fertigspritze mit Injektionslösung: Epoetinum Theta 30000 UI/ml | Teva Pharma AG | A | FB | | G |  |
| | | IP | CI | | EpoTheta-Teva 30'000 | 6 syringe(s) | | | k.A. | | Fertigspritze mit Injektionslösung: Epoetinum Theta 30000 UI/ml | Teva Pharma AG | A | FB | | G |  |
| | | | | | Recormon 500 U.I./0 | 10 ampoule(s) | | 130.40 | k.A. | | Injection preparation: Epoetinum Beta 500 UI | Roche Pharma (Schweiz) AG | A | FB | | G |  |
| | | | | | Recormon 1000 U.I./1 mL | 10 ampoule(s) | | | k.A. | | Injection preparation: Epoetinum Beta 1000 UI | Roche Pharma (Schweiz) AG | A | FB | | G |  |
| | | | | | Recormon 2000 U.I./1 mL | 10 ampoule(s) | | | k.A. | | Injection preparation: Epoetinum Beta 2000 UI | Roche Pharma (Schweiz) AG | A | FB | | G |  |
| | | | | | Recormon 5000 U.I./1 mL | 5 ampoule(s) | | 662.25 | k.A. | | Injection preparation: Epoetinum Beta 5000 UI | Roche Pharma (Schweiz) AG | A | FB | | G |  |
| | | | | | Recormon 10'000 U.I./mL | 5 ampoule(s) | | | k.A. | | Injection preparation: Epoetinum Beta 10000 UI | Roche Pharma (Schweiz) AG | A | FB | | G |  |
|
| L | SIP | IP | CI | | Aranesp 10 Mikrogramm | 4 syringe(s) | 85.17 | 109.05 | 10 % | | Injection solution in prefilled syringe: Darbepoetinum Alfa 10µg / 0.4ml | Amgen Switzerland AG | A / SL | FB | | G |  |
| L | SIP | IP | CI | | Aranesp 20 Mikrogramm | 4 syringe(s) | 169.11 | 200.35 | 10 % | | Injection solution in prefilled syringe: Darbepoetinum Alfa 20µg / 0.5ml | Amgen Switzerland AG | A / SL | FB | | G |  |
| L | SIP | IP | CI | | Aranesp 30 Mikrogramm | 4 syringe(s) | 254.23 | 292.90 | 10 % | | Injection solution in prefilled syringe: Darbepoetinum Alfa 30µg / 0.3ml | Amgen Switzerland AG | A / SL | FB | | G |  |
| L | SIP | IP | CI | | Aranesp 40 Mikrogramm | 4 syringe(s) | 337.49 | 383.45 | 10 % | | Injection solution in prefilled syringe: Darbepoetinum Alfa 40µg / 0.4ml | Amgen Switzerland AG | A / SL | FB | | G |  |
| L | SIP | IP | CI | | Aranesp 50 Mikrogramm | 4 syringe(s) | 422.82 | 476.25 | 10 % | | Injection solution in prefilled syringe: Darbepoetinum Alfa 50µg / 0.5ml | Amgen Switzerland AG | A / SL | FB | | G |  |
| L | SIP | IP | CI | | Aranesp 60 Mikrogramm | 4 syringe(s) | 507.62 | 568.50 | 10 % | | Injection solution in prefilled syringe: Darbepoetinum Alfa 60µg / 0.3ml | Amgen Switzerland AG | A / SL | FB | | G |  |
| L | SIP | IP | CI | | Aranesp 80 Mikrogramm | 4 syringe(s) | 676.32 | 751.95 | 10 % | | Injection solution in prefilled syringe: Darbepoetinum Alfa 80µg / 0.4ml | Amgen Switzerland AG | A / SL | FB | | G |  |
| L | SIP | IP | CI | | Aranesp 100 Mikrogramm | 4 syringe(s) | 843.40 | 933.65 | 10 % | | Injection solution in prefilled syringe: Darbepoetinum Alfa 100µg / 0.5ml | Amgen Switzerland AG | A / SL | FB | | G |  |
| L | SIP | IP | CI | | Aranesp 300 Mikrogramm | syringe(s) | 628.29 | 699.70 | 10 % | | Injection solution in prefilled syringe: Darbepoetinum Alfa 300µg / 0.6ml | Amgen Switzerland AG | A / SL | FB | | G |  |
| L | SIP | IP | CI | | Aranesp 500 Mikrogramm | syringe(s) | 1039.95 | 1147.40 | 10 % | | Injection solution in prefilled syringe: Darbepoetinum Alfa 500 µg/ml | Amgen Switzerland AG | A / SL | FB | | G |  |
| L | SIP | IP | CI | | Aranesp 150 Mikrogramm | 4 syringe(s) | 1259.26 | 1385.95 | 10 % | | Injection solution in prefilled syringe: Darbepoetinum Alfa 150µg / 0.3ml | Amgen Switzerland AG | A / SL | FB | | G |  |
| | SIP | IP | CI | | Aranesp 10 Mikrogramm | syringe(s) | | | k.A. | | Injection solution in prefilled syringe: Darbepoetinum Alfa 10µg / 0.4ml | Amgen Switzerland AG | A | FB | | G |  |
| | SIP | IP | CI | | Aranesp 20 Mikrogramm | syringe(s) | | | k.A. | | Injection solution in prefilled syringe: Darbepoetinum Alfa 20µg / 0.5ml | Amgen Switzerland AG | A | FB | | G |  |
| | SIP | IP | CI | | Aranesp 30 Mikrogramm | syringe(s) | | | k.A. | | Injection solution in prefilled syringe: Darbepoetinum Alfa 30µg / 0.3ml | Amgen Switzerland AG | A | FB | | G |  |
| | SIP | IP | CI | | Aranesp 40 Mikrogramm | syringe(s) | | | k.A. | | Injection solution in prefilled syringe: Darbepoetinum Alfa 40µg / 0.4ml | Amgen Switzerland AG | A | FB | | G |  |
| | SIP | IP | CI | | Aranesp 50 Mikrogramm | syringe(s) | | | k.A. | | Injection solution in prefilled syringe: Darbepoetinum Alfa 50µg / 0.5ml | Amgen Switzerland AG | A | FB | | G |  |
| | SIP | IP | CI | | Aranesp 60 Mikrogramm | syringe(s) | | | k.A. | | Injection solution in prefilled syringe: Darbepoetinum Alfa 60µg / 0.3ml | Amgen Switzerland AG | A | FB | | G |  |
| | SIP | IP | CI | | Aranesp 80 Mikrogramm | syringe(s) | | | k.A. | | Injection solution in prefilled syringe: Darbepoetinum Alfa 80µg / 0.4ml | Amgen Switzerland AG | A | FB | | G |  |
| | SIP | IP | CI | | Aranesp 100 Mikrogramm | syringe(s) | | | k.A. | | Injection solution in prefilled syringe: Darbepoetinum Alfa 100µg / 0.5ml | Amgen Switzerland AG | A | FB | | G |  |
| | SIP | IP | CI | | Aranesp 150 Mikrogramm | syringe(s) | | | k.A. | | Injection solution in prefilled syringe: Darbepoetinum Alfa 150µg / 0.3ml | Amgen Switzerland AG | A | FB | | G |  |
|
| | | | CI | H | Ferrodona | 100 ml | | 27.20 | k.A. | | Drops: 6 Active Agents | ebi-pharm ag | B | FB | | G |  |
| | | | CI | H | Dr. Reckeweg R 31 Contraemin | 50 ml | | | k.A. | | gouttes buvables: 4 Active Agents | Laboratoire Jacques Reboh et fils SA | D | FB | | G |  |
| | | | CI | H | Ferrodona | 50 ml | | 15.70 | k.A. | | Drops: 6 Active Agents | ebi-pharm ag | B | FB | | G |  |